Updates

Calnex

December 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The terrific sales momentum I described in the July issue continued into the first half. Sales were +38% to £12.7m, pretax profit +34% to £3.1m and eps +36% to 2.8p. Net cash came off from £15.4m six months ago to £14.3m following the in-period acquisition of iTrineg, a network emulation test vendor, for £2.5m. With 80% of revenues being invoiced in dollars, approximately a third of the growth in revenues was due to a strong dollar. There really wasn’t much to go through when I caught up with chief executive Tommy Cook following the results. Demand for Calnex’s telecoms testing equipment remains strong with the ongoing transition to 5G and the growth in cloud computing continuing to drive demand for test instrumentation and netw ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Braemar

AB Dynamics

Calnex (April 2023)

Calnex - Strong sales momentum continues (July 2022)

Calnex (January 2022)

Calnex (November 2021)

Calnex Solutions (September 2021)

Calnex (June 2021)

Calnex Solutions - Calnex Shares climb 143% in only two months! (January 2021)

Calnex Solutions - Neo beats expectations for 6 quarters (December 2020)

Calnex Solutions - 5G testing specialist (November 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X